Blood Test Can Identify Prostate Cancer Patients Who Are Not Likely to Respond to EnzalutamideAlice Goodman
"Only about a quarter of people who have a prostate biopsy due to an elevated PSA level are found to have prostate cancer. "There has therefore been a drive to create a new blood test with greater accuracy." The UEA team evaluated the new PSE test, which combines the traditional PSA tes...
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment. The new research paves the way for information from ablood testto informprostate cancer treatmentin f...
The researchers used CellSearch, a blood test that is already widely available, to identify patients who were unlikely to respond to standard treatment. The research was part of a phase 3 clinical trial of the SWOGCancerResearch Network, a partnership more than 1,300 institutions nationwide that ...
“Our findings show that any increase in prostate cancer cells circulating in the blood could identify patients with significantly poorer chances of survival, even at tiny levels, and could be used to guide treatment.” The researchers hope that the test will help with the rapid assessmen...
The Galleri multi-cancer early detection test is a proactive tool to screen for cancer. With a simple blood draw, the Galleri test can identify DNA shed by cancer cells, which can act as a unique “fingerprint” of cancer, to help screen for some ...
population-level screening: the ability to detect multiple deadly cancer types with a single test that has a very low false positive rate, and the ability to identify where in the body the cancer is located with high accuracy to help healthcare providers to direct next ste...
Finding the Wolf in Sheep's Clothing: The 4Kscore Is a Novel Blood Test That Can Accurately Identify the Risk of Aggressive Prostate Cancer. DJ. Finding the Wolf in Sheep's Clothing: the 4Kscore is a novel blood test that can accurately identify the risk of aggressive prostate cancer. ...
GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data ...
Can this blood test really detect cancer years before symptom appear? The early results are incredibly promising. Here's how it works.